☆ ☆ ☆ NEU: 7,25 % Österreich Plus Protect Aktienanleihe auf 📈 Erste Group 📈 OMV 📈 voestalpine - Jetzt handeln! ☆ ☆ ☆-w-
21.11.2019 17:48:00

Here's Why Karuna Therapeutics Is Tumbling Today

Shares of Karuna Therapeutics (NASDAQ: KRTX) fell more than 20% today after the company announced the pricing of a stock offering. The pharma company will offer up to nearly 3 million shares at $96 apiece, which is expected to raise gross proceeds of up to $288 million and will increase the number of shares outstanding by about 13%.Karuna Therapeutics is wisely taking advantage of a soaring share price. At the beginning of the week, the company reported solid results for its lead drug candidate, KarXT, in a phase 2 trial of acute psychosis in patients with schizophrenia. Shares gained as much as 750% by mid-week before receding to a weekly gain of "only" 400%.As of 11:06 a.m. EST, the pharma stock had settled to a 17.9% loss.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"